Abstract: Stable aqueous injectable Cisplatin solutions. The solutions comprise 0.1-1.0 mg/ml of Cisplatin, 9-15 mg/ml of NaCl and 0.025-0.075 mg/ml of citric acid. These solutions have the advantage of combining a mild pH range of 3.0-6.0 with a long shelf life.

Abstract: A stable, injectable pharmaceutical composition of vinca dimer salts. The compositions are in the form of an aqueous solution comprising per 1 ml of solution:from about 0.2 to about 2 mg of one or more pharmaceutically acceptable vinca dimer salts;from about 0.1 to about 1.0 mg of a pharmaceutically acceptable ethylenediamine-tetraacetic acid (EDTA) salt;acetate buffer in an amount necessary to maintain said aqueous solution at a pH of from about 3.0 to about 5.5; andfrom about 1.5 to about 2.5 mg of a preservative selected from methyl paraben, propyl paraben and mixtures thereof.